Project
The cell culture CDMO BIBITEC, a subsidiary of Nordmark Pharma, successfully commissioned its new GMP API production facility at the Nordmark plant in Uetersen in 2025.
D&N and network partners assumed project responsibility for the final steps of the project:
Achieving inspection-readiness and approval of manufactring authorization.


